China’s Sinovac offers inadequate protection against Omicron, study shows
Published
Hong Kong researchers say two doses of the jab provided ‘insufficient’ antibodies against new variant
Full ArticlePublished
Hong Kong researchers say two doses of the jab provided ‘insufficient’ antibodies against new variant
Full ArticleThe research suggests that the Chinese vaccine had little effect against Omicron and that the efficacy of the Pfizer-BioNTech..